Cite
HARVARD Citation
Chen, Z. et al. (2022). Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway. Bioengineered. 13 (5), pp. 12772-12782. [Online].